One Health Company announced a collaboration with IDEXX Laboratories, Inc. IDEXX Reference Laboratories will offer the FidoCure Next Generation DNA Sequencing Test to its veterinary customers in the United States and Canada later this month. The collaboration, which expands IDEXX's cancer care management portfolio, further enables veterinarians to deliver personalized care to their cancer patients by expanding access to FidoCure's precision medicine platform.